top of page
Rechercher
Jean Manuel Toussaint
4 juin 20201 min de lecture
France: New device on the liste en sus: Balt Silk embolization endoprosthesis
In France, the new embolization endoprosthesis named Silk (Balt) will be reimbursed €8,944.08 from June 10, 2020 #BALT #Embolization...
Jean Manuel Toussaint
4 juin 20201 min de lecture
France: New device on the liste en sus: SMT Supraflex Sirolimus DES
In France, the new coronary drug eluting stent (DES) named Supraflex (Sahajanand Medical Technologies - SMT) will be reimbursed €630 from...
Jean Manuel Toussaint
29 mai 20201 min de lecture
France: New device on the liste en sus: Abbott Amplatzer PFO Occluder
In France, the new Patent Foramen Ovale (PFO) occluder named Amplatzer (Abbott) will be reimbursed €3,735 from June 03, 2020 #Abbott,...
Jean Manuel Toussaint
14 mai 20201 min de lecture
France: New cut on the liste en sus: Peripheral Stents
In France, the tariffs of the covered, autoexpandable, balloon and drug eluting stents in vascular interventional market will be cut of...
Jean Manuel Toussaint
7 mai 20201 min de lecture
France: New cut on the liste en sus (V): In.Pact, Admiral, Medtronic, Drug Coated Balloon (DCB)
In France, the tariff of the drug Coated Balloon named "In.Pact Admiral" from Medtronic will be cut of -3.0% (€465.60) from May 11, 2020...
Jean Manuel Toussaint
7 mai 20201 min de lecture
France: New cut on the liste en sus (V): In.Pact, Admiral, Medtronic, Drug Coated Balloon (DCB)
In France, the tariff of the drug Coated Balloon named "In.Pact Admiral" from Medtronic will be cut of -3.0% (€465.60) from May 11, 2020...
Jean Manuel Toussaint
30 avr. 20201 min de lecture
France: New device on the liste en sus : C2F, Mercury, Hip, Cemented Cup
In France, the new cemented cup for hip named "Mercury" from C2F will be reimbursed €291.25 from April 30, 2020 #C2F #MERCURY #Hip...
Jean Manuel Toussaint
30 avr. 20201 min de lecture
France: New device on the liste en sus : C2F, Mercury, Hip, Cemented Cup
In France, the new cemented cup for hip named "Mercury" from C2F will be reimbursed €291.25 from April 30, 2020 #C2F #MERCURY #Hip...
Jean Manuel Toussaint
30 avr. 20201 min de lecture
France: New device on the liste en sus : PulmonX Zephyr, Endobronchial Valve
In France, the new unidirectional endobronchial valve named "Zephyr" from PulmonX will be reimbursed €2,374.16 from May 06, 2020 #PulmonX...
Jean Manuel Toussaint
30 avr. 20201 min de lecture
France: New device on the liste en sus : PulmonX Zephyr, Endobronchial Valve
In France, the new unidirectional endobronchial valve named "Zephyr" from PulmonX will be reimbursed €2,374.16 from May 06, 2020 #PulmonX...
Jean Manuel Toussaint
22 avr. 20201 min de lecture
France: New device on the liste en sus : Biotronik Biomonitor III, Implantable ECG
In France, the new implantable ECG named "Biomonitor III" from Biotronik will be reimbursed €1,530.93 from April 30, 2020 #Biotronik...
Jean Manuel Toussaint
22 avr. 20201 min de lecture
France: New device on the liste en sus : Biotronik Biomonitor III, Implantable ECG
In France, the new implantable ECG named "Biomonitor III" from Biotronik will be reimbursed €1,530.93 from April 30, 2020 #Biotronik...
Jean Manuel Toussaint
29 mars 20191 min de lecture
France : TAVI Market
Market growth was impressive over the last 5 years. 10,851 TAVI/TAVR were implanted in ~60 hospitals (2017). Edwards Lifescience still...
Jean Manuel Toussaint
29 mars 20191 min de lecture
France : TAVI Market
Market growth was impressive over the last 5 years. 10,851 TAVI/TAVR were implanted in ~60 hospitals (2017). Edwards Lifescience still...
Jean Manuel Toussaint
29 mars 20191 min de lecture
France : Neurovascular Stent Retrievers Market (2017)
In 2017, there were only 2 dominent Companies : Medtronic as the leader and Stryker as the challenger. In February 2019, Johnson &...
Jean Manuel Toussaint
29 mars 20191 min de lecture
France : Neurovascular Stent Retrievers Market (2017)
In 2017, there were only 2 dominent Companies : Medtronic as the leader and Stryker as the challenger. In February 2019, Johnson &...
bottom of page